平安好醫生(01833.HK)全年虧損收窄 股價借勢反覆續吐半成
平安好醫生(01833.HK)去年虧損收窄幅度超出市場預期,但始終仍蝕7.34億人民幣,加上受惠新冠肺炎過去一個月累積升幅不少,投資者繼續獲利回吐,拖累該股由上市高位連吐第二天,今早高開報77元欠承接,掉頭考驗10天線(71.06元),最低見70元,現造72.65元,續吐5%,成交增至1,332萬股,涉資9.6億元。
平安好醫生公布,去年虧損按年收窄19.5%至7.34億元人民幣(下同),低於市場預期虧損8.62億元;每股虧損0.73元,不派息。期內,收入按年增長51.8%至50.65億元,同樣高於市場預期之49.6億元。年內註冊用戶數3.15億人,過去12個月累增5,000萬人。每月活躍用戶人數按年增長22.3%至6,690萬人,每月付費用戶按年增長26%至300萬人。在線醫療收入按年增長1.09倍至8.58億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.